Understanding how CRISPR systems protect microbes from viruses
Molecular mechanisms of RNA-targeting CRISPR-Cas systems and their membrane-associated accessory proteins
This study is looking at how certain proteins help bacteria fight off viruses, which could lead to new ways to protect against viral infections.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project ID | NIH-11061220 on NIH RePORTER |
What this research studies
This research investigates the molecular mechanisms by which CRISPR-Cas systems, particularly the Cas13 enzyme and its accessory protein Csx28, work together to enhance microbial defense against viral infections. The study aims to uncover how these proteins interact and the role of RNA in activating Csx28's function. By employing techniques such as RNA sequencing and membrane biophysics, the research seeks to clarify the structural and functional details of these interactions, which could lead to the development of new antiviral tools.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would include individuals with viral infections or those interested in advanced therapeutic options involving CRISPR technology.
Not a fit: Patients with non-viral infections or those not affected by microbial defenses may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative strategies for phage therapy and the development of new molecular tools for combating viral infections.
How similar studies have performed: Other research has shown promise in understanding CRISPR systems, but the specific focus on membrane-associated proteins like Csx28 represents a novel approach.
Where this research is happening
Rochester, United States
- University of Rochester — Rochester, United States (Active)
Researchers
- Principal investigator: O'connell, Mitchell — University of Rochester
- Study coordinator: O'connell, Mitchell
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.